CME stock: buy or sell?

CME stock price: $203.48 -1.23% At close on July 16th, 2019

Updated on:
July 16th, 2019

4

After marking all time highs on Friday, CME decreased -1.23% today to $203.48.

CME Group Inc., through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide.

Should I buy CME stock?

Trading stocks requires experience and discipline, and your buying and selling decisions must come following a methodology. Having a trading plan helps to make decisions easier, quicker and with less hesitations. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.

Currently, 2 buy setups work for CME stock right now:

Buy setupElegible
New all-time highYes
New 52 week highYes
Price crossing up 200d MANo
100d MA crossing up 200d MANo

Is CME stock a buy?

Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness. At Stocks2.com, we detected 14 ratings published for CME stock in the last month.

Is CME a good stock to buy?
DateAnalyst / BrokerPrevious ratingCurrent rating
2019-7-3Wells Fargo & Con/aMarket Perform
2019-7-3Wells Fargo & Con/aMarket Perform
2019-7-3UBS Groupn/aNeutral
2019-6-5UBS Groupn/aNeutral
2019-5-23Barclaysn/aOverweight
2019-5-2UBS GroupNeutralNeutral
2019-5-2Citigroupn/aBuy
2019-3-26BarclaysOverweightOverweight
2019-3-22JPMorgan Chase & Co.n/aUnderweight
2019-3-15Deutsche BankBuyBuy
2019-2-15Sanford C. Bernsteinn/aOutperform
2019-2-15JPMorgan Chase & Co.NeutralUnderweight
2019-1-9Jefferies Financial Groupn/aBuy
2019-1-11Bank of AmericaBuyNeutral

CME stock analysis

Daily outlook

CME decreased -1.23% to $203.48 after topping to all time highs on Friday.

CME decreased -1.23% today to $203.48 after reaching all time highs on Friday. For the last 15 days when SMA100d and SMA200d crossed up, CME price gained $9.37 per share (4.83%). On May CME price bounced up over the SMA of 200 days demonstrating to be a significant support for this stock. On Friday, CME hit new all time highs, pushing higher previous ATH of $206.48 recorded on Thursday. New ATHs are usual entry points for many trading setups as there aren't higher resistences.

CME stock chart (daily)

Weekly outlook

Shares of CME closed this week at $203.48 and declined a rough -1.92%. Early June CME skyrocketed an impressive 5.30% in just one week.

CME stock is trading in the range of its last top and last bottom. Loosing would mean breaking the current uptrend. Breakdowns under last bottom are selling point signals for some trading strategies. Not so far away is the last price record CME marked last week. Since early July when SMA20w and SMA40w crossed up, CME price gained $9.37 per share (4.83%). Early May CME price bounced up over the SMA of 40 weeks that acted as support stopping new slides.

CME stock chart (weekly)

CME stock price history

CME stock went public on December 6th, 2002 with a price of $4.871. Since then, CME stock surged a 4,078.20%, with an average of 254.90% per year. If you had invested $1,000 in CME stock in 2002, it would worth $40,782.00 today.

1: Adjusted price after possible price splits or reverse-splits.

CME stock historical price chart

CME stock reached all-time highs on Friday with a price of $207.84.

CME stock price target is $193.80

How much a stock will be priced tomorrow or next week is quite unpredictable However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. For the last month we found 13 price targets for CME stock:
CME stock price predictions
DateAnalyst / BrokerActionPrevious targetCurrent targetDiff
2019-7-3Wells Fargo & CoReiterates$176.00$200.0013.6%
2019-7-3Wells Fargo & CoRaises Target$176.00$200.0013.6%
2019-7-3UBS GroupRaises Target$190.00$194.002.1%
2019-6-5UBS GroupRaises Target$175.00$190.008.6%
2019-5-23BarclaysRaises Target$191.00$197.003.1%
2019-5-2UBS GroupLowers Target$179.00$175.00-2.2%
2019-5-2CitigroupSet Price Targetn/a$202.00-
2019-3-26BarclaysLowers Target$210.00$193.00-8.1%
2019-3-22JPMorgan Chase & Co.Lowers Target$164.00$150.00-8.5%
2019-3-15Deutsche BankLowers Target$220.00$214.00-2.7%
2019-2-15Sanford C. BernsteinReiteratesn/a$210.00-
2019-1-9Jefferies Financial GroupReiteratesn/a$204.00-
2019-1-11Bank of AmericaReiterates$200.00$191.00-4.5%
(in average)$188.10$193.803.0%
Moving in a range from $214.00 and $150.00, the price target for CME stock is $193.80. In average, analysts' outlook on CME price forecast is positive, increasing the target by a 3.00% from previous estimations.

Financials and fundamental analysis

Earnings date and Earnings per Share

After posting its last earnings report on February, CME . Unfortunately, reported EPS is not yet available in our database.
CME earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise
2017-Q2-n/a1.22n/a
2017-Q32017-10-261.161.192.6%
2017-Q42018-02-011.091.122.8%
2018-Q12018-04-261.851.860.5%
2018-Q22018-07-261.721.741.2%
2018-Q32018-10-251.421.452.1%
2018-Q42019-02-141.751.771.1%
2019-Q1-n/an/an/a
2019-Q2-n/an/an/a
2019-Q3-n/an/an/a

Annual financial results

In 2018, CME annual sales boosted a super good 18.24% to $4,309.40 million dollars from $3,644.70 marked in 2017. When comparing 2018 vs 2017, nonetheless, profit margin (that is, the net income divided by revenues) plunged a -65.95% to 45.53%.

CME annual Sales and Income evolution
YearSalesYoYIncome/(margin)YoY
2013$2,930 M-$977 M33.3%-
2014$3,113 M6.23%$1,127 M36.2%15.39%
2015$3,327 M6.89%$1,247 M37.5%10.64%
2016$3,595 M8.07%$1,534 M42.7%23.02%
2017$3,645 M1.38%$4,063 M111.5%164.87%
2018$4,309 M18.24%$1,962 M45.5%-51.71%

Quarterly financial results

CME posted $1,236.60 M in sales for 2018-Q4, a 36.76% up compared to previous quarter. Reported quarter earnings marked $385.50 M with a profit margin of 31.17%. Profit margin plummed a -14.37% compared to previous quarter when profit margin was 45.54%. When comparing revenues to same quarter last year, CME sales marked a dazzling increase and rocketed a 37.40%.
CME quarterly Sales and Income evolution
QuarterSales1QoQ2Income1/(margin)QoQ2
2017-Q2$925 M-$416 M45.0%-
2017-Q3$891 M-3.66%$309 M34.6%-25.78%
2017-Q4$900 M1.03%$2,939 M326.6%852.43%
2018-Q1$1,109 M23.22%$599 M54.0%-79.63%
2018-Q2$1,060 M-4.45%$566 M53.4%-5.46%
2018-Q3$904 M-14.67%$412 M45.5%-27.26%
2018-Q4$1,237 M36.76%$386 M31.2%-6.39%
2019-Q1$1,180 M-4.61%$497 M42.1%28.90%

CME ownership

When you are planning to buy a stock, it's worth to overview its ownership structure.

Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For CME, 1.64% of all outstanding shares are owned by its staff.

Bearish positions for CME stock account 0.00%, no big difference from last month.

For a better context understanding, the following table shows ownership data compared to other related stocks:

CMECBOEIBKRICEMKTX
Market cap$72.8 B$0.0 M$0.0 M$51.8 B$13.6 B
Total shares358.0 M0.0 M0.0 M563.9 M37.7 M
Float shares348.9 M0.0 M0.0 M557.5 M36.3 M
  - Institutional holdings (%)87.9%0.0%0.0%0.0%106.0%
  - Insider holdings (%)1.6%0.0%0.0%93.2%2.6%
Shares in short selling0.0%0.0%0.0%0.0%0.0%

CME summary

Tuesday, July 16th, 2019
Open$206.67
Close$203.48
Day range$203.30 - $207.18
Previous close$206.02
Session gain-1.23%
Average true range$3.22
50d mov avg$193.37
100d mov avg$182.42
200d mov avg$181.31
Daily pattern
Weekly pattern lt06a

CME performance

Performance as an absolute value is never valid if it's not benchmarked against competitors or related stocks in the industry. In the following table, we compare CME to Cboe Global Markets, Interactive Brokers, Intercontinental Exchange, MarketAxess, MSCI and Nasdaq:
Stock3m6m12m
CME 15.81%11.83%23.51%
CBOECboe Global Marke...12.97%20.71%10.37%
IBKRInteractive Broke...-7.48%-6.89%-18.55%
ICEIntercontinental ...15.43%22.33%22.80%
MKTXMarketAxess36.94%65.27%73.06%
MSCI 9.42%46.41%43.16%
NDAQNasdaq16.38%26.63%11.92%

CME competitors

One check before investing in any stock is to have a look a list of its competitors, in this case for CME. We picked 6 companies as CME competitors as they are in the same industry or have similar market objectives.

Latest CME stock news